Will Anti-Aging Breakthroughs Arrive in Time for Us?

Will Anti-Aging Breakthroughs Arrive in Time for Us?

From The Game of Life by Alexis Wilson

November 27, 2025 · 4 min

About this episode

The episode discusses the potential arrival of anti-aging breakthroughs and their implications for healthspan in our lifetime.

People wonder whether anti-aging breakthroughs will actually arrive in time for them to benefit. In this video, we look at what’s already in human trials, what’s coming next, and the realistic timelines for genuine aging-targeted therapies. We cover: • The current pipeline of drugs that target aging biology (rapamycin analogs, senolytics, NAD⁺ restoration, GLP-1s, SGLT2 inhibitors, metformin) • What nutrition trials revealed about slowing biological aging in healthy adults • Why epigenetic clocks are accelerating human geroscience research • How long it takes for mouse longevity interventions to translate into real human therapies • Why the 2030s are the likely decade for the first true “healthspan drugs” • The odds of people under 50 living long enough to benefit from multiple therapy waves • Why adding healthy years now drastically increases your chance of reaching future breakthroughs The real question isn’t immortality, it’s whether treatments that add 5–15 extra healthy years will arrive within our lifetime. For most adults today, the answer is very likely yes. If you want longevity guidance and clear explanations of what actually moves the needle, subscribe. There’s much…

Topics covered

  • anti-aging
  • healthspan
  • geroscience
  • longevity therapies

Keywords

  • aging biology
  • human trials
  • nutrition trials
  • epigenetic clocks
  • healthspan drugs

Mentioned in this episode

Products: rapamycin analogs, senolytics, NAD⁺ restoration, GLP-1s, SGLT2 inhibitors, metformin

More episodes of The Game of Life

Explore listener stats, chart rankings, contacts and more on the The Game of Life podcast page.